https://www.selleckchem.com/pr....oducts/vls-1488-kif1
hange in route of administration from repeated intrathecal administration to oral medication. Improvements in motor/breathing function, broad indication, oral or one-time infusion, and minimal risk were preferred treatment attributes. Treatment decisions should be made in clinical context and be tailored to patient needs. Improvements in motor/breathing function, broad indication, oral or one-time infusion, and minimal risk were preferred treatment attributes. Treatment decisions should be made in clinical context and be ta
Like
Comment
Share
